Krystal Biotech, Inc. (KRYS)

Krystal Biotech Revenue

Krystal Biotech had revenue of $119.22M in the quarter ending June 30, 2026, with 24.14% growth. This brings the company's revenue in the last twelve months to $440.48M, up 22.63% year-over-year. In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth.

• Revenue (ttm): $440.48M
• Revenue Growth: +22.63%
• P/S Ratio: 22.65
• Revenue / Employee: $1,493,166
• Employees: 295
• Market Cap: 9.98B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	389.13M	98.62M	33.94%
Dec 31, 2024	290.52M	239.82M	473.02%
Dec 31, 2023	50.70M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error